Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · IEX Real-Time Price · USD

5.75

-0.03 (-0.52%)

At close: Jul 19, 2024, 4:00 PM

5.67

-0.08 (-1.39%)

Pre-market: Jul 20, 2024, 9:27 AM EDT

BDTX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Selling, General & Admin	27	27.11	28.39	30.04	21.36	7.58	Upgrade
Research & Development	58.14	59.35	64.44	96.83	48.21	21.75	Upgrade
Operating Expenses	85.15	86.46	92.83	126.87	69.57	29.33	Upgrade
Operating Income	-85.15	-86.46	-92.83	-126.87	-69.57	-29.33	Upgrade
Interest Expense / Income	0	0	0	0	0	0	Upgrade
Other Expense / Income	-5.35	-4.02	-1.66	-1.28	-2.32	5.93	Upgrade
Pretax Income	-79.79	-82.44	-91.17	-125.6	-67.25	-35.26	Upgrade
Net Income	-79.79	-82.44	-91.17	-125.6	-67.25	-35.26	Upgrade
Shares Outstanding (Basic)	52	44	36	36	33	2	Upgrade
Shares Outstanding (Diluted)	52	44	36	36	33	2	Upgrade
Shares Change	42.00%	21.00%	0.38%	9.97%	1485.31%	2.83%	Upgrade
EPS (Basic)	-1.66	-1.88	-2.52	-3.47	-2.05	-16.99	Upgrade
EPS (Diluted)	-1.66	-1.88	-2.52	-3.47	-2.05	-16.99	Upgrade
Free Cash Flow	-67.82	-66.66	-85.27	-102.86	-52.29	-24.7	Upgrade
Free Cash Flow Per Share	-1.31	-1.52	-2.35	-2.84	-1.59	-11.90	Upgrade
EBITDA	-79.39	-82.01	-90.66	-125.39	-67.2	-35.21	Upgrade
Depreciation & Amortization	0.4	0.44	0.51	0.21	0.05	0.05	Upgrade
EBIT	-79.79	-82.44	-91.17	-125.6	-67.25	-35.26	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).